Organ-level tissue engineering using bioreactor systems and stem cells: Implications for transplant surgery

Current Stem Cell Research and Therapy

Volumn 9, Issue 1, 2014, Pages 2-9

  Rennert, Robert C ^a   Sorkin, Michael ^a   Wong, Victor W ^a   Gurtner, Geoffrey C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft; Bioreactor; Complex tissue engineering; Stem cells; Vascularized composite allotransplantation

Indexed keywords

ALLOGRAFTS; BIOREACTORS; BLOOD VESSELS; HUMANS; STEM CELLS; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 84904503575     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X113086660069     Document Type: Article

References (65)

1. Petruzzo P, Dubernard JM. The International Registry on Hand and Composite Tissue allotransplantation. Clin Transpl 2011: 247-53.
2. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2008; 86(4): 487-92.
3. Cendales LC, Rahmel A, Pruett TL. Allocation of vascularized composite allografts: what is it? Transplantation 2012; 93(11): 1086-7.
4. Guibert EE, Petrenko AY, Balaban CL, et al. Organ Preservation: Current Concepts and New Strategies for the Next Decade. Transfus Med Hemother 2011; 38(2): 125-42.
5. Pradka SP, Ong YS, Zhang Y, et al. Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model. Transplant Proc 2009; 41(2): 531-6.
6. Nishikawa H, Manek S, Barnett SS, et al. Pathology of warm ischaemia and reperfusion injury in adipomusculocutaneous flaps. Int J Exp Pathol 1993; 74(1): 35-44.
7. Wagh M, Pantazi G, Romeo R, et al. Cold storage of rat skeletal muscle free flaps and pre-ischemic perfusion with modified UW solution. Microsurgery 2000; 20(7): 343-9.
8. Huang WC, Lin JY, Wallace CG, et al. Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts. Clin Dev Immunol 2012; 2012: 107901.
9. Barth RN, Rodriguez ED, Mundinger GS, et al. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transplant 2011; 11(7): 1407-16.
10. Herold C, Reimers K, Allmeling C, et al. A normothermic perfusion bioreactor to preserve viability of rat groin flaps extracorporally. Transplant Proc 2009; 41(10): 4382-8.
11. Badylak SF, Weiss DJ, Caplan A, et al. Engineered whole organs and complex tissues. Lancet 2012; 379(9819): 94352.
12. Rennert RC, Sorkin M, Garg RK, et al. Stem cell recruitment after injury: lessons for regenerative medicine. Regen Med 2012; 7(6): 833-50.
13. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14(2): 213-21.
14. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010; 16(8): 927-33.
15. Asnaghi MA, Jungebluth P, Raimondi MT, et al. A double-chamber rotating bioreactor for the development of tissue- engineered hollow organs: from concept to clinical trial. Biomaterials 2009; 30(29): 5260-9.
16. Cebotari S, Lichtenberg A, Tudorache I, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006; 114(1 Suppl): I132-7.
17. Carrel A, Lindbergh CA. The Culture of whole organs. Science 1935; 81(2112): 621-23.
18. Vogel T, Brockmann JG, Friend PJ. Ex-vivo normothermic liver perfusion: an update. Curr Opin Organ Transplant 2010; 15(2): 167-72.
19. Sivertsson L, Synnergren J, Jensen J, et al. Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor. Stem Cells Dev 2013; 22(4): 581-94.
20. Fonsato V, Herrera MB, Buttiglieri S, et al. Use of a rotary bioartificial liver in the differentiation of human liver stem cells. Tissue Eng Part C Methods 2010; 16(1): 123-32.
21. Chang EI, Bonillas RG, El-ftesi S, et al. Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds. FASEB J 2009; 23(3): 906-15.
22. Go T, Jungebluth P, Baiguero S, et al. Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg 2010; 139(2): 437-43.
23. Shafa M, Krawetz R, Zhang Y, et al. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes. BMC Cell Biol 2011; 12: 53.
24. Cendales L, Granger D, Henry M, et al. Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee. Am J Transplant 2011; 11(1): 13-7.
25. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2010; 90(12): 1590-4.
26. Suzuki K. Cold ischemic damage to bone. J Reconstr Microsurg. 1991; 7(3): 179-85.
27. Tsujino A, Hayashi K, Koshima I. Hypothermic preservation of peripheral nerve grafts: A histomorphometric study. J Orthop Sci 1996; 1: 329-34.
28. Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002; 73(5): 701-9.
29. St Peter SD, Imber CJ, Lopez I, et al. Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg 2002; 89(5): 609-16.
30. Medeiros IL, Pego-Fernandes PM, Mariani AW, et al. Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion. J Heart Lung Transplant 2012; 31(3): 305-9.
31. Sadaria MR, Smith PD, Fullerton DA, et al. Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion. Ann Thorac Surg 2011; 92(2): 478-84.
32. George TJ, Arnaoutakis GJ, Beaty CA, et al. A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform. J Surg Res 2013; 183(1): 75-83
33. Rucker M, Schafer T, Roesken F, et al. Local heat-shock priming-induced improvement in microvascular perfusion in osteomyo- cutaneous flaps is mediated by heat-shock protein 32. Br J Surg 2001; 88(3): 450-7.
34. Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet 2012; 380(9856): 1851-8.
35. Lu S, Yu Y, Gao Y, et al. Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats. Hepatobiliary Pancreat Dis Int 2008; 7(3): 258-63.
36. Xiao B, Xia W, Zhao K, et al. Ex vivo transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of rapamycin therapy prolongs free flap allograft survival. Plast Reconstr Surg 2011; 127(5): 1820-9.
37. Wang GM, Ma JB, Jin YZ, et al. Long-term survival of cardiac allografts induced by cyclophosphamide combined with CTLA4Ig- gene transfer mediated by adenoviral vector. Transplant Proc 2006; 38(9): 3043-5.
38. Xu Y, Gong B, Yang Y, et al. Adenovirus-mediated overexpre-ssion of glutathione-s-transferase mitigates transplant arterio- sclerosis in rabbit carotid allografts. Transplantation 2010; 89(4): 409-16.
39. Ghali S, Bhatt KA, Dempsey MP, et al. Treating chronic wound infections with genetically modified free flaps. Plast Reconstr Surg 2009; 123(4): 1157-68.
40. Dempsey MP, Hamou C, Michaels Jt, et al. Using genetically modified microvascular free flaps to deliver local cancer immunotherapy with minimal systemic toxicity. Plast Reconstr Surg 2008; 121(5): 1541-53.
41. Furukawa H, Oshima K, Tung T, et al. Liposome-mediated combinatorial cytokine gene therapy induces localized synergistic immunosuppression and promotes long-term survival of cardiac allografts. J Immunol 2005; 174(11): 6983-92.
42. Agrawal VK, Copeland KM, Barbachano Y, et al. Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery. Gene Ther 2009; 16(1): 78-92.
43. Chen ZY, He CY, Ehrhardt A, et al. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003; 8(3): 495-500.
44. Glotzbach JP, Wong VW, Gurtner GC, et al. Regenerative medicine. Curr Probl Surg 2011; 48(3): 148-212.
45. Hyun JS, Montoro DT, Lo DD, et al. The seed and the soil: optimizing stem cells and their environment for tissue regeneration. Ann Plast Surg 2013; 70(2): 235-9.
46. Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102(10): 3837-44.
47. Zhou HP, Yi DH, Yu SQ, et al. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant Proc 2006; 38(9): 3046-51.
48. Oshima K, Cui G, Tung T, et al. Exogenous IL-10 overexpression reduces perforin production by activated allogenic CD8+ cells and prolongs cardiac allograft survival. Am J Physiol Heart Circ Physiol 2007; 292(1): H277-284.
49. Larsen M, Willems WF, Pelzer M, et al. Augmentation of surgical angiogenesis in vascularized bone allotransplants with host-derived a/v bundle implantation, fibroblast growth factor-2, and vascular endothelial growth factor administration. J Orthop Res 2010; 28(8): 1015-21.
50. Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature 2008; 453(7193): 314-21.
51. Nagasue N, Yukaya H, Ogawa Y, et al. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987; 206(1): 30-9.
52. Tanaka T, Hirose M, Kotobuki N, et al. Bone augmentation by bone marrow mesenchymal stem cells cultured in three- dimensional biodegradable polymer scaffolds. J Biomed Mater Res A 2009; 91(2): 428-35.
53. Baba S, Inoue T, Hashimoto Y, et al. Effectiveness of scaffolds with pre-seeded mesenchymal stem cells in bone regeneration-- assessment of osteogenic ability of scaffolds implanted under the periosteum of the cranial bone of rats. Dent Mater J 2010; 29(6): 673-81.
54. Ben-David D, Kizhner TA, Kohler T, et al. Cell-scaffold transplant of hydrogel seeded with rat bone marrow progenitors for bone regeneration. J Craniomaxillofac Surg 2011; 39(5): 364-71.
55. Nguyen LH, Kudva AK, Saxena NS, et al. Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel. Biomaterials 2011; 32(29): 6946-52.
56. Nguyen LH, Kudva AK, Guckert NL, et al. Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials 2011; 32(5): 1327-38.
57. Liu L, Wu W, Tuo X, et al. Novel strategy to engineer trachea cartilage graft with marrow mesenchymal stem cell macroaggregate and hydrolyzable scaffold. Artif Organs 2010; 34(5): 426-33.
58. Schmelzer E, Mutig K, Schrade P, et al. Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multi-compartment 3D perfusion bioreactors for extra-corporeal liver support. Biotechnol Bioeng 2009; 103(4): 817-27.
59. Schmidt D, Dijkman PE, Driessen-Mol A, et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 2010; 56(6): 510-20.
60. Matsuura K, Wada M, Konishi K, et al. Fabrication of mouse embryonic stem cell-derived layered cardiac cell sheets using a bioreactor culture system. PLoS One 2012; 7(12): e52176.
61. Wang Y, Zhang Y, Zhang S, et al. Rotating microgravity-bioreactor cultivation enhances the hepatic differentiation of mouse embryonic stem cells on biodegradable polymer scaffolds. Tissue Eng Part A 2012; 18(21-22): 2376-85.
62. Matsuura K, Wada M, Shimizu T, et al. Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun 2012; 425(2): 321-7.
63. Rustad KC, Wong VW, Sorkin M, et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012; 33(1): 80-90.
64. Wong VW, Rustad KC, Glotzbach JP, et al. Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Macromol Biosci 2011; 11(11): 1458-66.
65. Wong VW, Rustad KC, Galvez MG, et al. Engineered pullulan-collagen composite dermal hydrogels improve early cutaneous wound healing. Tissue Eng Part A 2011; 17(5-6): 631-44.